Surgical Quality Improvement

Orthopaedic Surgery Outcomes

Orthopaedic Surgery ACS NSQIP Outcomes

January 1, 2022 – December 31, 2022

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall orthopaedic surgery ACS NSQIP performance benchmarked against 597 participating sites.

Orthopaedic Surgery (597 Sites)NObservedExpected
30 Day Mortality6430.31%0.44%
30 Day Morbidityᵃ6432.49%4.28%
Unplanned Intubation6430.31%0.29%
Ventilator > 48 Hours6430.31%0.06%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus6431.09%0.85%
Renal Failure6430.31%0.47%
Urinary Tract Infection (UTI)6430.16%0.65%
Surgical Site Infection (SSI)6430.93%1.77%
C.diff Colitis6430.00%0.09%
Unplanned Reoperation6431.40%2.33%
Unplanned Readmission6435.91%4.66%

American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.

ᵃIdentified as a statistical outlier (lower than expected) by the ACS NSQIP hierarchical model.